Krista Goodman

Krista Goodman has over 25 years of experience in the pharmaceutical industry. Krista'srecent role includes SVP Drug Discovery for a Biotech Company in Stealth Mode in 2021. Krista held several leadership positions at GlaxoSmithKline (GSK) since 2002, including Global Head and Senior Director of Flexible Medicinal Chemistry, Medicine Design, Global Head of Medicinal Chemistry, Drug Design and Selection Platform, Director of Chemistry and Preclinical Development, and Manager of Chemistry at Heart Failure Discovery Performance Unit. In addition, they also served as the Chair of GSK Chemistry Council. Krista started their career as a Research Associate in Combinatorial Chemistry at Chiron in 1995. Currently, they will be joining Larkspur Biosciences as their Chief Scientific Officer in 2022, where they will lead the development of precision immunotherapy for patients with molecularly defined populations to overcome tumor-induced immune responses.

Krista Goodman earned their Bachelor of Science degree in Chemistry from the University of California, Berkeley between 1991 and 1995. Krista then went on to attend Harvard University from 1996 to 2002, where they earned both their Master of Science and Doctor of Philosophy degrees in Chemistry.